Intrahepatic T cells in hepatitis B: viral control versus liver cell injury.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

29 citing papers in PubMed.

1. Interleukin-21 responses in patients with chronic hepatitis B.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2015
   Trial
2. Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis.PLoS pathogens · 2013
   Trial
3. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.Journal of clinical immunology · 2004
   Trial
4. HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
   Review
5. Recent advances in molecular mechanisms to improve the efficacy of CAR-T cell therapy for viral diseases, cancer, and autoimmune diseases.Stem cell research & therapy · 2026
   Review
6. Research Progress on the Mechanism of Persistent Low-Level HBsAg Expression in the Serum of Patients with Chronic HBV Infection.Journal of immunology research · 2022
   Review
7. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana.Viruses · 2020
   Article
8. Prognostic Value of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in Patients With Single Tumor Size ≤ 5 cm Hepatocellular Carcinoma After Radical Resection.Frontiers in oncology · 2019
   Article
9. Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus.PloS one · 2016
   Article
10. Hepatitis B virus infection: An insight into infection outcomes and recent treatment options.Virusdisease · 2015
    Review
11. The chimpanzee model for hepatitis B virus infection.Cold Spring Harbor perspectives in medicine · 2015
    Review
12. The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury.Protein & cell · 2014
    Article
13. Regulatory role of CD4(+)CD25 (+)Foxp3 (+) regulatory T cells on IL-17-secreting T cells in chronic hepatitis B patients.Digestive diseases and sciences · 2014
    Article
14. Expression levels of CD28, CTLA-4, PD-1 and Tim-3 as novel indicators of T-cell immune function in patients with chronic hepatitis B virus infection.Biomedical reports · 2014
    Article
15. Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular Carcinoma.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2013
    Review
16. Scavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injury.Hepatology (Baltimore, Md.) · 2013
    Article
17. Relationship between HBV genotypes B, C and follicular helper T cells in patients with chronic hepatitis B and its significance.Hepatitis monthly · 2013
    Article
18. Alteration in cellular immunity after chronic hepatitis B deteriorated into severe hepatitis and its significance.Hepatitis monthly · 2011
    Article
19. Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.Journal of virology · 2011
    Article
20. Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action.Clinical rheumatology · 2010
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as